Fundz

Clarapath raised $36M in a Series B-1 funding round led by Northwell Ventures to transform 150-year old laboratory processes

PRIVATEJul 24, 2024

Amount Raised

$36 Million

Round Type

Series B

New YorkBiotechnologyHealthcareHealth CareMedicalMedical DeviceHealth Diagnostics

Investors

Ochsner VenturesMayo ClinicCU Healthcare Innovation FundNorthwell Ventures

Description

Clarapath, a medical robotics company modernizing and transforming how pathology laboratories process tissue, announced a $36 million Series B-1 funding round led by Northwell Ventures. Additional strategic investors such as CU Healthcare Innovation Fund, Mayo Clinic, and Ochsner Ventures also participated in the financing, bringing the company's total funding to $75 million.

Quick answer

Clarapath raised $36 Million in a Series B round, dated July 24, 2024. Investors: Ochsner Ventures, Mayo Clinic, CU Healthcare Innovation Fund and Northwell Ventures. Clarapath is based in New York, New York, United States.

How much did Clarapath raise?
Clarapath raised $36 Million in a Series B round on July 24, 2024.
Who invested in Clarapath?
Ochsner Ventures, Mayo Clinic, CU Healthcare Innovation Fund and Northwell Ventures are named as investors in this round.
What does Clarapath do?
Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work.
Where is Clarapath based and how big is it?
Clarapath is based in New York, New York, United States.
Who are the decision-makers at Clarapath?
Fundz holds 1 contact at Clarapath. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Clarapath that raised within 45 days of this round, from Fundz verified event records.

  • Segmed raised $10M (Series A) on September 3, 2024.
  • Flyte raised $496K (Seed) on September 3, 2024.
  • Otolith Labs raised $4.9M (Series A) on July 29, 2024.
  • JaxBio Technologies raised $2.7M (Grant) on July 24, 2024.
  • PulseMedica raised $12M (Pre-Series A) on July 16, 2024.
  • HEPTA Medical raised $6.3M (Series A) on September 4, 2024.

Who to call at Clarapath, and when

A new round usually means Clarapath is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Clarapath raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Clarapath, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Clarapath. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Clarapath

Location

New York, New York, United States

About

Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work. Clarapath is developing tools and workflow solutions to improve outcomes and reduce costs in clinical and non-clinical pathology. With the rising demand for sample reviews and the reliance on a dwindling labor pool, Clarapath's SectionStar provides automated sectioning for non-clinical and clinical pathology laboratories. SectionStar is the first, fully automated, all-in-one tissue sectioning and transfer system that will dramatically increase capacity, reliability, and consistency while minimizing the need for highly skilled labor. Clarapath is headquartered and runs its medical device development in Hawthorne, NY. It also has a CLIA-certified Clinical Research Organization (CRO) that serves clinical and research organizations by processing tissue, performing whole slide imaging, and providing automated image processing based in New York City at the New York Genome Center.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Clarapath raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Clarapath. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Clarapath's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Clarapath raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.